Healthcare provider profile · identity verified

Dayron Morey, APRN

Nurse Practitioner · MIAMI, FL · NPI 1982305157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	97
Amlodipine Besylate	Amlodipine Besylate	396	65
Gabapentin	Gabapentin	347	67
Furosemide	Furosemide	276	60
Losartan Potassium	Losartan Potassium	272	41
Lisinopril	Lisinopril	267	50
Metformin Hcl	Metformin Hcl	262	44
Pantoprazole Sodium	Pantoprazole Sodium	257	52
Eliquis	Apixaban	206	43
Tamsulosin Hcl	Tamsulosin Hcl	198	37
Metoprolol Tartrate	Metoprolol Tartrate	197	36
Levothyroxine Sodium	Levothyroxine Sodium	196	37
Hydrochlorothiazide	Hydrochlorothiazide	162	25
Glipizide	Glipizide	148	22
Levetiracetam	Levetiracetam	148	27
Metoprolol Succinate	Metoprolol Succinate	146	25
Clopidogrel	Clopidogrel Bisulfate	145	31
Baclofen	Baclofen	137	24
Trazodone Hcl	Trazodone Hcl	130	34
Famotidine	Famotidine	118	27
Rosuvastatin Calcium	Rosuvastatin Calcium	111	31
Carvedilol	Carvedilol	107	26
Bumetanide	Bumetanide	96	20
Omeprazole	Omeprazole	94	22
Quetiapine Fumarate	Quetiapine Fumarate	94	38
Montelukast Sodium	Montelukast Sodium	93	14
Divalproex Sodium	Divalproex Sodium	86	19
Hydralazine Hcl	Hydralazine Hcl	86	20
Nifedipine Er	Nifedipine	83	16
Potassium Chloride	Potassium Chloride	77	15
Megestrol Acetate	Megestrol Acetate	72	20
Mirtazapine	Mirtazapine	67	20
Sertraline Hcl	Sertraline Hcl	67	19
Fenofibrate	Fenofibrate Nanocrystallized	65	11
Buspirone Hcl	Buspirone Hcl	62	14
Entresto	Sacubitril/Valsartan	62	suppressed
Finasteride	Finasteride	61	14
Simvastatin	Simvastatin	60	suppressed
Allopurinol	Allopurinol	58	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	58	18
Levofloxacin	Levofloxacin	56	44
Ibuprofen	Ibuprofen	54	14
Donepezil Hcl	Donepezil Hcl	53	16
Latanoprost	Latanoprost	53	14
Naproxen	Naproxen	53	11
Lactulose	Lactulose	52	14
Lantus	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Benztropine Mesylate	Benztropine Mesylate	46	13
Risperidone	Risperidone	46	16
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	43	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Levemir	Insulin Detemir	37	suppressed
Memantine Hcl	Memantine Hcl	37	15
Hydrocortisone	Hydrocortisone	36	suppressed
Mupirocin	Mupirocin	36	suppressed
Ammonium Lactate	Ammonium Lactate	35	15
Spironolactone	Spironolactone	35	suppressed
Midodrine Hcl	Midodrine Hcl	34	14
Meloxicam	Meloxicam	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Methylprednisolone	Methylprednisolone	32	24
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	16
Prednisone	Prednisone	30	suppressed
Naproxen Sodium	Naproxen Sodium	29	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Atenolol	Atenolol	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Olanzapine	Olanzapine	25	12
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Valsartan	Valsartan	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	23	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Topiramate	Topiramate	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	13
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Retacrit	Epoetin Alfa-Epbx	20	suppressed
Vascepa	Icosapent Ethyl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Haloperidol	Haloperidol	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Cephalexin	Cephalexin	18	15
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Cefdinir	Cefdinir	17	15
Lorazepam	Lorazepam	17	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Bupropion Xl	Bupropion Hcl	14	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Linzess	Linaclotide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Procrit	Epoetin Alfa	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Ethambutol Hcl	Ethambutol Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Letrozole	Letrozole	11	suppressed
Perphenazine	Perphenazine	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error